SEELQ: Seelos Therapeutics, Inc. Stock

by  •  • Comments Off on SEELQ: Seelos Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.76
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Jane Street Group, Llc 6.60
02-14 13G/A Lind Global Fund II LP 0.00 -100.00
12-04 13G/A AdvisorShares Trust 4.71 -86.52
11-25 13G Weber Mark 10.70

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
RTSL – Rapid Therapeutic Science Laboratories, Inc. RVLPQ – RVL Pharmaceuticals plc
SCPS – Scopus BioPharma Inc. SGBI – Sangui Biotech International, Inc.
SGFEF – Siegfried Holding AG


Financial data and stock pages provided by
Fintel.io